Latest Pfizer News | Page 3

Covid vaccine safety report – 24-08-2023
Covid vaccine safety report – 10-08-2023
New AusBiotech report shows increasing US investment in Australian biotechs
Iraq eliminates trachoma as a public health problem
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
AstraZeneca appoints Sharon Barr as Executive Vice President BioPharmaceuticals R&D
Unapproved GMOs in Pfizer and Moderna mRNA Covid-19 vaccines, court case alleges
Covid vaccine safety report – 27-07-2023
RSV is everywhere right now. What parents need to know about respiratory syncytial virus
TGA Product Information safety updates 24 July
Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 July
Covid vaccine safety report – 29-06-2023
‘The dirty disease’ – both smokers and non-smokers get lung cancer. They face stigma on top of illness
TGA Product Information safety updates 23 June
Covid vaccine safety report – 15-06-2023
Australians believe COVID-19 risk is ‘new normal’, yet with winter here, COVID-safe behaviours are in decline
Vaxxas appoints former Pfizer executive as chief medical officer
Product Information safety updates – April and May 2023
Covid vaccine safety report – 01-06-2023
Covid vaccine weekly safety report – 18-05-2023
UWA and Bridgewest Perth Pharma announce new partnership
Covid vaccine safety report – 04-05-23
Covid vaccine safety report – 20-04-23
Wonder drug-capsule may one day replace insulin injection for diabetics
Pregnant this winter? Here’s how to prepare for COVID and get vaccinated
RSV vaccine for pregnant women provides protection for babies: study
Covid vaccine safety report – 06-04-23
Pfizer’s COVID-19 oral anti-viral available to more Australians on the Pharmaceutical Benefits Scheme from 1 April
TGA Product Information safety updates 27 March
Covid vaccine safety report – 23-03-2023
UW study investigates how ‘vaccine shopping’ impacts rollout during pandemic
Covid vaccine safety report – 09-03-2023
TGA Product Information safety updates 2 March
Australian Cell and Gene Catalyst takes step forward
ATAGI recommendations on use of Moderna bivalent Covid vaccine
Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once
Covid vaccine safety report – 23-02-2023
TGA provisionally approves Moderna’s new bivalent Covid vaccine
New booster plan in time for winter
TGA grants provisional approval to Moderna’s COVID-19 bivalent (SPIKEVAX Bivalent Original/Omicron BA.4-5) booster dose vaccine
Victorian Heart Hospital opens: First dedicated heart hospital in the Southern Hemisphere and new home of Monash cardiovascular research
Final days to nominate stroke hero
Covid vaccine safety report – 09-02-23
Haven’t had COVID or a vaccine dose in the past six months? Consider getting a booster
COVID-19 vaccine available for younger children at higher risk of severe illness
ATAGI recommendations on use of Pfizer bivalent Covid vaccine 8 February
ATAGI 2023 booster advice
New research uncovers what Australians consider most important when it comes to their health